The European Union's pharmaceutical sector is in a ongoing state of transformation. With exacting regulations, increasing patient expectations, and the rapid pace of research, navigating this intricate landscape requires a strategic approach. Pharmaceutical companies must evolve to this changes by adopting cutting-edge technologies, collaborating w